Comparison SAB Biotherapeutics (SABS) with Competitors
SAB Biotherapeutics (SABS) industry is Biotechnology.
Free Cash Flow Yield
SABS-19.50%
Industry-1.94%
Upside-17.56%
P/E
SABS14.06
Industry-18.88
Upside+3293.60%
P/S
SABS2.96
Industry9.28
Upside-68.12%
P/B
SABS1.21
Industry4.70
Upside-74.33%